Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma

Alexandra J. Greenberg, S. Vincent Rajkumar, Dirk R. Larson, Angela Dispenzieri, Terry M. Therneau, Colin L. Colby, Tara K. Phelps, Shaji K. Kumar, Jerry A. Katzmann, Robert A. Kyle, Susan L. Slager, Celine M. Vachon

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Previously, we reported increased risk of heavy-chain (HC) monoclonal gammopathy of undetermined significance (MGUS) among first-degree (1°) relatives of multiple myeloma (MM) or HC-MGUS probands. This study investigated whether there was comparable risk for light-chain (LC) MGUS among 911 relatives of the same HC-MGUS/MM probands versus a reference population of 21 463. Seventeen 1° relatives had LC-MGUS (adjusted prevalence = 1·7%, 95% CI = 0·9-2·6%). There was increased risk of LC-MGUS in relatives of MM probands (RR = 3·4, 95% CI = 2·0-5·5). We saw no increased risk in relatives of HC-MGUS probands. We conclude that the prevalence of LC-MGUS is significantly higher among 1° relatives of MM probands compared to the reference population.

Original languageEnglish (US)
Pages (from-to)472-475
Number of pages4
JournalBritish journal of haematology
Volume157
Issue number4
DOIs
StatePublished - May 2012

Keywords

  • Epidemiology
  • MGUS
  • Myeloma

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma'. Together they form a unique fingerprint.

Cite this